Quick Answer
Minerva Neurosciences, Inc. reported Net Income Loss of -$293.42 million for the year ending 2025.
- Minerva Neurosciences, Inc. showed a decrease of -20,492.7% in Net Income Loss from 2024 to 2025.
- This data is from Minerva Neurosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), Minerva Neurosciences, Inc.'s Net Income Loss has declined by 415.7%.
- Historical annual values: Fiscal year 2025: -$293.42 million | Fiscal year 2024: $1.44 million | Fiscal year 2023: -$30.01 million | Fiscal year 2022: -$32.11 million | Fiscal year 2021: -$49.91 million | Fiscal year 2020: $1.94 million | Fiscal year 2019: -$72.18 million | Fiscal year 2018: -$50.17 million | Fiscal year 2017: -$31.52 million | Fiscal year 2016: -$31.05 million | Fiscal year 2015: -$27.08 million | Fiscal year 2014: -$56.90 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: